Thank you, sir, for your question.
We try to track what kind of supply happens in our market. One of the key responses is pill testing—testing the substances that circulate and are used by the users. I think it's very important to have that in place in order to identify early what is circulating.
Apart from that, we are working on the education of people, on the availability of naloxone and on preparing people for something we expect will come to the European market with the same kind of availability you notice in your country.